Target intelligence / Profile preview

Histamine Release via IgE-Mediated Mast Cell Activation (N/A)

Target
N/A
Molecular classification
Signaling pathway, Immune response
01

Overview

Histamine release via IgE-mediated mast cell activation is a critical effector mechanism in type I hypersensitivity reactions. It involves allergen-driven cross-linking of surface-bound IgE on FcεRI-expressing mast cells leading to rapid degranulation with subsequent local or systemic inflammatory effects that underpin many allergic disorders. Regulation occurs at multiple levels including receptor expression modulated by cytokines and circulating antibody concentration. This pathway remains a major target for anti-allergy drug development due to its central role in disease pathogenesis.

Other names
IgE-mediated mast cell degranulationMast cell activationType I hypersensitivity reactionAllergic cascade
02

Mechanism of action

N/A

03

Biological functions

Immune responseInflammationAllergic reactionMast cell degranulation
04

Disease associations

Allergic rhinitisAsthmaAnaphylaxisUrticariaAtopic dermatitisInflammatory diseases
05

Safety considerations

AnaphylaxisSide effects of antihistamines (e.g., drowsiness)Immunogenicity of anti-IgE therapiesSteroid-related adverse effects
06

Interacting drugs

Antihistamines

4 more in the full profile.

07

Biomarkers

Serum IgE levelsHistamine levelsMast cell mediators (e.g., tryptase)Allergen-specific IgE

Beyond the preview

Go deeper on Histamine Release via IgE-Mediated Mast Cell Activation (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histamine Release via IgE-Mediated Mast Cell Activation (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call